SPY366.02+3.96 1.09%
DIA298.44+1.82 0.61%
IXIC12,355.11+156.37 1.28%

Exicure, Inc Awarded U.S Patent 10,837,01 'Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use'

Exicure, Inc Awarded U.S Patent 10,837,01 'Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use'

· 11/17/2020 06:22
Exicure, Inc Awarded U.S Patent 10,837,01 'Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use'